|
Market Closed -
Nasdaq
01:30:00 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 21.09 USD | -2.86% |
|
+14.37% | -8.34% |
| 28/09 | Damora Therapeutics Insider Bought Shares Worth $252,875, According to a Recent SEC Filing | MT |
| 21/09 | Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to S&P Global BMI Index | CI |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DMRA | Delayed | |
CBOE
| DMRA | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Neutral |
| Resistance | 22.85 | 24.9 | 34.14 |
| Spread/Res. | -7.70% | -15.30% | -38.22% |
| Spread/Supp. | +14.43% | +14.43% | +25.76% |
| Support | 18.43 | 18.43 | 16.77 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DMRA Stock
- Charts Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions

















